Home / Stocks / Blue Jet Healthcare Ltd
BLUEJET

Blue Jet Healthcare Ltd Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹516.85

Change

-1.6 (-0.31%)

Open

₹518.45

Prev. Close

₹518.45

Day High

₹526.95

Day Low

₹511.8

Volume Analysis

Traded

232,297

Delivered

101,063

Delivery %

43.51%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (2)

  • •Strong return on equity (52.1%)
  • •Strong operating margin (41.0%)

Weaknesses (1)

  • •Promoter holding is falling

Opportunities (0)

No signal for this stock

Threats (1)

  • •FII holding has been falling

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹540.41 ₹533.68 ₹525.26 ₹518.53 ₹510.11 ₹503.38 ₹494.96
Fibonacci ₹533.68 ₹527.89 ₹524.32 ₹518.53 ₹512.74 ₹509.17 ₹503.38
Camarilla ₹521.02 ₹519.63 ₹518.24 ₹518.53 ₹515.46 ₹514.07 ₹512.68

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

-2.3%

1 Week

-4.16%

1 Month

+4.33%

3 Months

-13.3%

6 Months

+17.19%

1 Year

-10.58%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

DuPont ROE Breakdown

40.04%

Net margin 27.25% × asset turnover 0.93x × equity multiplier 1.58x

Company Overview

Sector

Healthcare

Market Cap

₹9,989 Cr

P/E (TTM)

70.9

ROE

52.1%

Face Value

₹2.0

Source: Screener.in (Consolidated figures) — data as of 16 Nov 2026. Not investment advice.

TopFund Analysis

Blue Jet Healthcare Ltd lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 61/100. The strongest factor is Financial Strength (100/100), while Valuation (2/100) is the weakest area to weigh before deciding. Notably: Strong return on equity (52.1%); strong operating margin (41.0%); promoter holding is falling. FII holding has been falling.

TopFund Score — Fundamentals Quality

61/100 — Average

Data confidence: 75/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

100

Valuation

2

Cash Flow

65

Corporate Governance

43

Momentum

63

Institutional Ownership

36

Business Quality

100

Risk & Volatility

28

Liquidity

53

From Screener.in

  • +Company has reduced debt.

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Signed non-binding MoU with Andhra Pradesh for phased ₹500 crore API manufacturing facility on 50 acres.

Transcript of Earnings call with analysts/Investors on Financial Result for the Quarter and Half Yearly ended 30th September, 2026.

Newspaper Publication of Financial Results pertaining to Quarter and half year ended September 30, 2026

Audio recording of Q2 and H1 FY2026 earnings conference call posted on website.

CARE monitoring report for Blue Jet’s ₹800 crore QIP; ₹245.91 crore utilized, no deviation.

Source: BSE regulatory filings, via Screener.in.

Profit & Loss (Yearly)

  Mar 2020 Mar 2021
Sales + 538 499
Expenses + 324 293
Operating Profit 214 206
OPM % 40.0% 41.0%
Other Income + 6 4
Interest 7 5
Depreciation 18 20
Profit before tax 194 185
Tax % 25.0% 26.0%
Net Profit + 145 136
EPS in Rs 138 8
Dividend Payout % 0.0% 0.0%
Sales growth — -7

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2020 Mar 2021
Reserves 201 330
Borrowings + 79 53
Other Liabilities + 95 143
Total Liabilities 375 536
Fixed Assets + 107 139
CWIP 2 3
Investments 34 37
Other Assets + 232 358
Total Assets 375 536
Equity Capital 1 10

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2020 Mar 2021
Cash from Operating Activity + 123 129
Cash from Investing Activity + -45 -51
Cash from Financing Activity + -72 -28
Net Cash Flow 5 51
Free Cash Flow 107 80
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 80 63

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 86.0% → 73.15%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Public 7.37% 8.97% 9.83% 10.06% 10.87% 10.38% 11.08% 14.74% 14.41% 14.8% 15.14% 18.56%
Promoters 86.0% 86.0% 86.0% 86.0% 86.0% 86.0% 86.0% 79.81% 79.81% 79.81% 79.81% 73.15%
FII 2.93% 2.01% 2.02% 2.18% 1.1% 2.28% 1.97% 1.83% 1.14% 0.89% 0.4% 0.81%
DII 3.7% 3.04% 2.14% 1.75% 2.02% 1.33% 0.95% 3.63% 4.65% 4.51% 4.65% 7.48%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Blue Jet Healthcare Ltd (this stock) 9,989 70.9 — 52.1%
Yatharth Hosp & Tra C S L 10,222 53.6 5.44 10.2%
Symbiotec Pharmalab Ltd 10,354 70.0 7.6 11.7%
Jupiter Life Line Hosp L 9,507 50.0 5.84 13.1%
Strides Pharma Sci Ltd 9,353 16.2 2.74 20.0%
Paras Healthcare Limited 9,284 129.0 — 13.0%
Aarti Pharmalabs Limited 9,212 35.4 4.08 8.59%

Which Mutual Funds Hold Blue Jet Healthcare Ltd?

Frequently Asked Questions about Blue Jet Healthcare Ltd

Community Sentiment

What are other investors saying about Blue Jet Healthcare Ltd?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.